MAVROLEON BASIL G 4

What Happened
Director Basil G. Mavroleon received multiple grants/awards of restricted stock units (RSUs) on May 26, 2026. The filing lists eleven separate RSU awards totaling approximately 1,798.83 RSUs (individual amounts include 383.97, 299.31, 227.17, 193.51, 134.62, 125.21, 115.67, 92.55, 90.43, 109.57 and 26.82). Each award is reported as acquired at $0.00 per unit (derivative award), which is typical for RSU grants; the Form 4 shows no cash purchase or sale.

Key Details

• Transaction date: May 26, 2026 (Report filed May 28, 2026). Filing marked late (transactionTimeliness = 'L').
• Type: A = Grant/Award (derivative RSUs). Price reported: $0.00 per RSU. Total units awarded: ~1,798.83 RSUs.
• Shares owned after transaction: Not specified in the provided summary of the filing.
• Notable footnotes: F1 explains each RSU equals the right to one share (or cash value at vesting); F10–F11 note some RSUs vested on May 23, 2024 and May 20, 2025; F12 describes a vesting rule (earlier of next annual meeting or 14 months after grant); F13 covers additional RSUs issued in lieu of cash dividends. Several other footnotes (F2–F9) reference past vesting dates for earlier grants.
• No indication in this filing of immediate sale, tax-withholding shares surrendered, a 10b5-1 plan, or other disposition.

Context
These are equity compensation awards, not open-market purchases or sales. RSUs are derivative awards that convert to shares (or cash) upon vesting according to the terms noted in the footnotes; they do not necessarily signal buying or selling intent. The filing was marked late, which delays public disclosure of the awards by the insider.